Antithesis Raises $105M Series A as AI-Generated Code Drives Testing Demand

Antithesis, a deterministic software testing platform, closed a $105 million Series A round led by quantitative trading firm Jane Street, valuing the company at $525 million and signaling mounting pressure on developers to validate rapidly proliferating AI-generated code. The round, announced December 3, 2025, represents a 2.4× jump from the company's $215 million Series A valuation in 2024 and marks a decisive validation of an emerging category: autonomous testing via deterministic simulation rather than traditional example-based methods.